Defence Therapeutics (TSE:DTC) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Defence Therapeutics Inc., a Canadian biopharmaceutical company, has announced a private placement of up to $4.2 million to support its preclinical and clinical programs. The offering consists of seven million units, each comprising a common share and a warrant, aimed at advancing the company’s innovative radiopharmaceutical and ADC products.
For further insights into TSE:DTC stock, check out TipRanks’ Stock Analysis page.
